Member Info for marik

Hope it goes well and yes looking forward to more positive days.

"Great SP movement this morning, very happy but just hope we can hold onto the rise since we have more sells than buys"

Excellent rise today. The pressure on the share price will build in anticipation of the big result. A quick question to the long term holders, (wyndn71, not you), where do you see the price after positive results?

"its stating the obvious"

LOL. The statement has to be true first before it becomes the obvious. If it was true that all news is already built into the sp, the sp wouldn't fluctuate.

GL to LTH

"Would you prefer It if I...?"

As you are asking, what I'd like you to stop making statements like this:

"Every forecast, every RNS, ever rumour, every tipsheet commentator, its all already in the SP."

Your predictions are basic.

@wynd Clearly you're not great at predicting the share price. You bought 11.12p in anticipation of it rising and yet you were trading at a 7% loss (prior to any recent rise). As you said, in your world; "Every forecast, every RNS, ever rumour, every tipsheet commentator, its all already in the SP.", you clearly didn't see this coming. All the other comments you've made are from the Grand Old Duke of York:

And when they were up, they were up
And when they were down, they were down
And when they were only half-way up
They were neither up nor down

That sums up a chartists ability on this BB as BASIC

Just to add, (this won't concern you wyndy), for the LTH this share has huge potential and I'll be awaiting the next drill update in great excitement 10x returns by Hannam looks possible.

GL to All LTH

Yes, its turned around dramatically.

"Marik, seemed concerned by my simplistic approach"

And yet you didn't see this coming. Try some other ancient techniques like crystal ball gazing, leaches, sticky sticks or perhaps pop on some sun glasses and take off your shirt.

Great news today. Keep the positive posts near the top. There is room for the price to go > 18.5p.

It's interesting that Hannam were conservative in their prediction of £1.33 which places HE1 at >10x upside from the current levels.

As mentioned before the sp was artificially deflated, and today's rectification is a fraction of where this will be even without news i.e. >18p. One of the reasons, is the discovery of the helium system as evidenced by the radioactivity and the helium shows.

The current share price will recover dramatically and I'll be adding over the next few weeks and look forward to the news.

GLA

Abingdon Health would be great.

"I was talking about P1 and P2 as in the RNS whereas they are called 1a and 1b on the FDA link"

Let's leave it at that. I'm sure it's been a long day, even 4D had a 1% rise with lot's of positives to come from them.

Have a good day.

"Phase 1 is just to find the maximum possible dose of AVA6000."

Don't start splitting phase 1a and 1b, you specifically mentioned all of phase 1. If you don't know the answer or don't know what you are talking about, give it a rest.

This statement by you says nothing about what I'm asking you. Prove that "the *only* Ava6k news we will get is on the pharmo-kinetics "

Here is the clinical trials website to help you out, and it is titled:

A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours

https://www.clinicaltrials.gov/ct2/show/NCT04969835

(Pretend you are no longer sitting in Norwich with your sunglasses)

"The first patient has received their first dose of AVA6000 at The Royal Marsden NHS Foundation Trust. The Phase I study is being initiated across a small group of leading UK cancer centres with an established reputation for early cancer clinical research in the Phase I setting. The dose escalation phase is anticipated to complete by Q2 2022 followed by completion of the dose expansion phase by Q2 2023."

So that's a no then. You're making off the cuff comments and have nothing to back it up. Prove that "the *only* Ava6k news we will get is on the pharmo-kinetics "

Here is the clinical trials website to help you out, and it is titled:

A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours

https://www.clinicaltrials.gov/ct2/show/NCT04969835

Just copy and paste the title back as a response.

@Sangijuelas1 Don't Change the Subject.

" and the only Ava6k news we will get is on the pharmo-kinetics of the various doses, which will not be a strong indicator of efficacy."

That's the statement you made, now prove that "the *only* Ava6k news we will get is on the pharmo-kinetics "

Here is the clinical trials website to help you out, and it is titled:

A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours

https://www.clinicaltrials.gov/ct2/show/NCT04969835

Go for it.

" and the only Ava6k news we will get is on the pharmo-kinetics of the various doses, which will not be a strong indicator of efficacy."

That's the statement you made, now prove that "the *only* Ava6k news we will get is on the pharmo-kinetics "

Here is the clinical trials website to help you out, and it is titled:

A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours

https://www.clinicaltrials.gov/ct2/show/NCT04969835

Go for it.

"Phase 1 is just to find the maximum possible dose of AVA6000."

I said evidence, do not just repeat yourself.

" and the only Ava6k news we will get is on the pharmo-kinetics of the various doses, which will not be a strong indicator of efficacy."

Why don't you enlighten us Sangijuelas1, your making these statements, back it up with a link or evidence.

If a broken crystal ball could talk, it might say... No.

Good point Knotagain. Myles provided a great quality write up and he's quite genuine.